Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01241916 · ClinicalTrials.gov registry record · NA

A Prospective Randomized Trial of Static-Progressive Versus Dynamic Splinting for Post-Traumatic Elbow Stiffness

A NA study of Post-traumatic Stiff Elbows, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
66
Enrollment target
1
Study location

NCT01241916 is a NA study of Post-traumatic Stiff Elbows that has completed, run by Massachusetts General Hospital. The registered enrollment target is 66 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01241916, a NA study of Post-traumatic Stiff Elbows, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
66 participants
Enrollment target
1
Study location

Study Summary

Primary Question: "When splinting is used to improve motion in post-traumatic stiff elbows, is there a significant difference in gains in motion achieved between static progressive or dynamic splint approaches?" Secondary Question: "Is there a significant difference in patient compliance with static progressive versus dynamic splint use, and does this effect final ulnohumeral motion outcomes?"

Interventions

  • DEVICE Static-Progressive Splint
  • DEVICE Dynamic Splint

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2003-08
Est. Completion 2010-09
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT01241916

The ClinicalTrials.gov registry entry for NCT01241916 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Post-traumatic Stiff Elbows appearing as the primary indexed condition, and to 2 interventions - of which Static-Progressive Splint is the first listed.

NCT01241916 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01241916 about?

NCT01241916 is a clinical study titled "A Prospective Randomized Trial of Static-Progressive Versus Dynamic Splinting for Post-Traumatic Elbow Stiffness". Primary Question: "When splinting is used to improve motion in post-traumatic stiff elbows, is there a significant difference in gains in motion achieved between static progressive or dynamic splint approaches?" Secondary Question: "Is there a significant difference in patient compliance with stati...

What is the current status of trial NCT01241916?

This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2003-08. Estimated completion is 2010-09.

What conditions does trial NCT01241916 study?

This clinical trial studies the following conditions: Post-traumatic Stiff Elbows.

What interventions are being tested in trial NCT01241916?

The interventions under investigation include: Static-Progressive Splint (DEVICE), Dynamic Splint (DEVICE).

Who is sponsoring clinical trial NCT01241916?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01241916 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.